Top Institutions in Ophthalmology
Leading academic ophthalmology centers with strong retinal disease research programs and clinical trial expertise in anti-VEGF therapies typically conduct and publish pivotal studies like ELARA, leveraging advanced imaging and treatment protocols for AMD and DME.
-
#1
Bascom Palmer Eye Institute
Miami, FL
Bascom Palmer is consistently ranked as a top ophthalmology center with extensive expertise in retinal diseases and anti-VEGF clinical trials, contributing significantly to advancements in AMD and DME treatments.
Key Differentiators
- Ophthalmology
- Retina
- Clinical Trials
-
#2
Massachusetts Eye and Ear Infirmary
Boston, MA
Massachusetts Eye and Ear has a robust retinal research program and is known for its leadership in clinical trials for wet AMD and diabetic eye diseases, including anti-VEGF treatment protocols.
Key Differentiators
- Ophthalmology
- Retina
- Clinical Research
-
#3
Wills Eye Hospital
Philadelphia, PA
Wills Eye is a leading center for retinal disease management and research, with a history of conducting pivotal clinical trials in AMD and DME therapies including flexible dosing regimens.
Key Differentiators
- Ophthalmology
- Retina
- Clinical Trials
-
#4
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute is renowned for its translational research in retinal diseases and has contributed to the development and evaluation of novel therapies for AMD and DME.
Key Differentiators
- Ophthalmology
- Retina
- Clinical Research
-
#5
University of California, San Francisco (UCSF) Medical Center
San Francisco, CA
UCSF has a prominent ophthalmology department with active research in retinal diseases and anti-VEGF treatment optimization, including flexible dosing strategies for AMD and DME.
Key Differentiators
- Ophthalmology
- Retina
- Clinical Trials
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.







